Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

News Features

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Michael O'Riordan

December 18, 2019

News Conference News TCT 2019

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Shelley Wood

September 29, 2019

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

Presentation TCT 2019

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

Presenter: Suzanne Baron

September 29, 2019

Presentation TCT 2019

COAPT: Cost-Effectiveness Analysis From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

Presenter: Suzanne Baron

September 29, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Four: Costs and Quality of Life Take Center Stage

Shelley Wood

September 29, 2019

Presentation TCT 2019

To Close or Not to Close the PFO: Incorporation of Patient Preferences and Shared Decision-Making

Presenter: Suzanne Baron

September 27, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Suzanne Baron About the Cost-Effectiveness Analysis from COAPT and Health Status Outcomes from PARTNER 3

September 29, 2019

Advertisement

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

COAPT: Cost-Effectiveness Analysis From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

TCT 2019 Day Four: Costs and Quality of Life Take Center Stage

To Close or Not to Close the PFO: Incorporation of Patient Preferences and Shared Decision-Making

Dr. C. Michael Gibson Talks With Dr. Suzanne Baron About the Cost-Effectiveness Analysis from COAPT and Health Status Outcomes from PARTNER 3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content